¡GoConqr estrena diseño! Cuéntanos qué te parece.

Diagrama de flujo

Neurocognitive Pharmacology

Usuario eliminado El usuario ha eliminado su información de asignaturas Inglés

Contenido del diagrama

  1. Donezepil-Aricept

  2. Rivastigmine-Exelon

  3. Galantamine-Razadyne

  4. Memantine-Namenda

  5. Selective AChE Inhibitor

  6. General Information

  7. AChE Inhibitor

  8. Inhibits Acetilcolinesterasa

  9. Acetilcolinesterasa breaks down ACh

  10. By inhibiting AChE, there is more ACh in the system

  11. This can result in a betterment of memory

  12. Mostly effective at early Dx

  13. Not very effective at later stages

  14. Given at Initial, moderate and severe stages

  15. In CNS and PNS

  16. Do to interaction with PNS, will generate GI Sx

  17. Tx: Varying types of dementia

  18. -Alzheimer's

    -Parkinson's

    -Lewy bodies dementia

    -Vascular dementia

  19. S-E: Nausea, vomiting, diarrhea, muscle cramps, fatigue, weight loss

  20. Will usually last 1-3 weeks

  21. AChE and BuChE inhibitor

  22. BuChE inhibitor

  23. Inhibits butyrylcholinesterase

  24. butyrylcholinesterase breaks down butyrylcholine

  25. butyrylcholine is very similiar to ACh

  26. By inhibiting BuCHe in glial cells, there is more ACh in the system

  27. This results in regulation of Dementia patients

  28. Glial Cells: provides physical and metabolic support to neurons, including neuronal insulation and communication, and nutrient and waste transport.

  29. Given in fast progression

  30. Tx: Mild to Moderate Alzheimer's

  31. S-E: Nausea, vomiting, diarrhea, weight loss, indigestion, muscle weakness

  32. Selective AChE Inhibitor

  33. Given at Initial, moderate and severe stages

  34. Function: Neurocogntiive and behavioral

  35. Function: Neurobehavioral

  36. Function: Slow down neuropsicological deterioration

  37. Tx: Mild to Moderate Alzheimer's & Vascular dementia

  38. S-E: Dizziness, nausea, vomiting, diarrhea, decreased appetite, headache

  39. Stimulates nicotinic receptors to release more acetylcholine in the brain

  40. NMDA receptor antagonist

  41. Given at moderate and severe stages, usually in cojunction with Donezepil

  42. Function: Neurocognitive functions

  43. Blocks the toxic effects associated with excess glutamate and regulates glutamate activation

  44. Prevents the breakdown of acetylcholine

  45. Prevents the breakdown of acetylcholine in the brain

  46. Prevents the breakdown of acetylcholine and butyrylcholine (a brain chemical similar to acetylcholine) in the brain

  47. Tx: Moderate to severe Alzheimer's disease & sometimes Vascular dementia

  48. S-E: Constipation, Dizziness, headache, diarrhea, confusion

  49. Only given when there is loss of language and motor function

Información

Descripción
El usuario ha eliminado su información de asignaturas Diagrama sobre Neurocognitive Pharmacology, creado por Usuario eliminado el 07/03/2022.
Creado por
Usuario eliminado · mar 2022
Actualizado
7 mar 2022
Visitas
20
Historial
  • Creado por J.J. Lopez · 7 mar 2022
  • Copiado por J.J. Lopez · 7 mar 2022
Valoración

Escríbenos

¿Sobre qué es tu mensaje?

¿Qué te parece el nuevo diseño?

¿Te gusta?